Found: 64
Select item for more details and to access through your institution.
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. e1149, doi. 10.1093/oncolo/oyae079
- By:
- Publication type:
- Article
Tumor-size responses to first-line is a predictor of overall survival in metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39026-y
- By:
- Publication type:
- Article
Is EUS-guided drainage a suitable alternative technique in case of proximal biliary obstruction?
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 7, p. 537, doi. 10.1177/1756283X17702614
- By:
- Publication type:
- Article
RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.639675
- By:
- Publication type:
- Article
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6756, doi. 10.3390/ijms22136756
- By:
- Publication type:
- Article
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10489-4
- By:
- Publication type:
- Article
Management of biliary tract cancers in early‐onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1886, doi. 10.1111/liv.15922
- By:
- Publication type:
- Article
Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment.
- Published in:
- International Journal of Colorectal Disease, 2009, v. 24, n. 6, p. 605, doi. 10.1007/s00384-009-0672-8
- By:
- Publication type:
- Article
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first-line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 4, p. 1433, doi. 10.3892/ijo.2019.4709
- By:
- Publication type:
- Article
Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221118019
- By:
- Publication type:
- Article
Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 7, p. 4436, doi. 10.1245/s10434-024-15196-x
- By:
- Publication type:
- Article
Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 877, doi. 10.1245/s10434-019-07976-7
- By:
- Publication type:
- Article
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 440, doi. 10.1038/s41416-021-01624-2
- By:
- Publication type:
- Article
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 73, doi. 10.1007/s10120-019-00983-3
- By:
- Publication type:
- Article
Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 3, p. 323, doi. 10.1016/j.molonc.2012.10.008
- By:
- Publication type:
- Article
Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 7, p. e571, doi. 10.1093/oncolo/oyac055
- By:
- Publication type:
- Article
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1870, doi. 10.1002/onco.13888
- By:
- Publication type:
- Article
Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 555, doi. 10.1634/theoncologist.2011-0365
- By:
- Publication type:
- Article
Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5079, doi. 10.1002/cam4.2311
- By:
- Publication type:
- Article
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 ( MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 4, p. 676, doi. 10.1002/cam4.635
- By:
- Publication type:
- Article
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53271-6
- By:
- Publication type:
- Article
Gene Expression Patterns of Hemizygous and Heterozygous <i>KIT</i> Mutations Suggest Distinct Oncogenic Pathways: A Study in NIH3T3 Cell Lines and GIST Samples.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061103
- By:
- Publication type:
- Article
Practical considerations in the use of regorafenib in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920956862
- By:
- Publication type:
- Article
PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.
- Published in:
- Cellular & Molecular Life Sciences, 2017, v. 74, n. 22, p. 4231, doi. 10.1007/s00018-017-2579-9
- By:
- Publication type:
- Article
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 18, p. 3290, doi. 10.1002/cncr.29471
- By:
- Publication type:
- Article
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
- Published in:
- World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02594-2
- By:
- Publication type:
- Article
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
- Published in:
- 2016
- By:
- Publication type:
- journal article
How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 1, p. 109, doi. 10.1245/s10434-018-6931-6
- By:
- Publication type:
- Article
Cancer du rectum : vers une personnalisation du traitement néoadjuvant en 2023.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Quelles évolutions dans la prise en charge des tumeurs digestives ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 6, p. 629, doi. 10.1684/hpg.2023.2603
- By:
- Publication type:
- Article
Cancer du pancréas métastatique : stratégies thérapeutiques actuelles dans le domaine théranostique.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 4, p. 429, doi. 10.1684/hpg.2023.2571
- By:
- Publication type:
- Article
La cancérologie (hors cancer colorectal et hépato-carcinome).
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 8, p. 819, doi. 10.1684/hpg.2020.2034
- By:
- Publication type:
- Article
Adénocarcinome du pancréas métastatique : prise en charge en 2020.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 6, p. 585, doi. 10.1684/hpg.2020.1987
- By:
- Publication type:
- Article
Prise en charge des tumeurs du pancréas localement avancées.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2017, v. 24, n. 8, p. 813, doi. 10.1684/hpg.2017.1504
- By:
- Publication type:
- Article
Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA.
- Published in:
- Clinical Chemistry, 2016, v. 62, n. 11, p. 1492, doi. 10.1373/clinchem.2016.258236
- By:
- Publication type:
- Article
Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1234, doi. 10.3390/cancers13061234
- By:
- Publication type:
- Article
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3866, doi. 10.3390/cancers12123866
- By:
- Publication type:
- Article
hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1808, doi. 10.3390/cancers11111808
- By:
- Publication type:
- Article
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 998, doi. 10.3390/cancers11070998
- By:
- Publication type:
- Article
Treatment of Pancreatic Cancer: What Can We Really Predict Today?
- Published in:
- Cancers, 2011, v. 3, n. 1, p. 675, doi. 10.3390/cancers3010675
- By:
- Publication type:
- Article
A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.
- Published in:
- Application of Clinical Genetics, 2010, v. 3, p. 85, doi. 10.2147/TACG.S7191
- By:
- Publication type:
- Article
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article